These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11668222)

  • 1. Paraoxonase genotype modifies the effect of pravastatin on high-density lipoprotein cholesterol.
    Malin R; Laaksonen R; Knuuti J; Janatuinen T; Vesalainen R; Nuutila P; Lehtimäki T
    Pharmacogenetics; 2001 Oct; 11(7):625-33. PubMed ID: 11668222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.
    Malin R; Knuuti J; Janatuinen T; Laaksonen R; Vesalainen R; Nuutila P; Jokela H; Laakso J; Jaakkola O; Solakivi T; Lehtimäki T
    J Mol Med (Berl); 2001 Aug; 79(8):449-58. PubMed ID: 11511975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men.
    Malin R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Pasanen M; Oja P; Bond G; Koivula T; Lehtimäki T
    Metabolism; 2001 Sep; 50(9):1095-101. PubMed ID: 11555845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
    Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia.
    Leus FR; Wittekoek ME; Prins J; Kastelein JJ; Voorbij HA
    Atherosclerosis; 2000 Apr; 149(2):371-7. PubMed ID: 10729387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. R192Q paraoxonase gene variant is associated with a change in HDL-cholesterol level during dietary caloric restriction in nondiabetic healthy males.
    Obata T; Ito T; Yonemura A; Ayaori M; Nakamura H; Ohsuzu F
    J Atheroscler Thromb; 2003; 10(1):57-62. PubMed ID: 12621166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis.
    Malin R; Järvinen O; Sisto T; Koivula T; Lehtimäki T
    Atherosclerosis; 2001 Aug; 157(2):301-7. PubMed ID: 11472729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipid levels and M/L55 allele distribution of HDL paraoxonase gene in Saami and Finnish men.
    Malin R; Lehtinen S; Luoma P; Näyhä S; Hassi J; Koivula T; Lehtimäki T
    Int J Circumpolar Health; 2001 Jan; 60(1):16-24. PubMed ID: 11428219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cholesterol-lowering on plasma membrane lipids and function.
    Lijnen P; Echevaría-Vázquez D; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration.
    Kujiraoka T; Oka T; Ishihara M; Egashira T; Fujioka T; Saito E; Saito S; Miller NE; Hattori H
    J Lipid Res; 2000 Aug; 41(8):1358-63. PubMed ID: 10946025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
    Rahimi-Ardabili B; Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Naghavi-Behzad M; Ghorashi S; Nezami N
    Ren Fail; 2012; 34(9):1123-8. PubMed ID: 22950600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy.
    Lahoz C; Peña R; Mostaza JM; Jiménez J; Subirats E; Pintó X; Taboada M; López-Pastor A;
    Atherosclerosis; 2003 Jun; 168(2):289-95. PubMed ID: 12801612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nandrolone decanonate on paraoxonase activity in hemodialysis patients.
    Ghorbanihaghjo A; Argani H; Rahbaninoubar M; Rashtchizadeh N
    Clin Biochem; 2005 Dec; 38(12):1076-80. PubMed ID: 16153628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of red grape seed extract on serum paraoxonase activity in patients with mild to moderate hyperlipidemia.
    Argani H; Ghorbanihaghjo A; Vatankhahan H; Rashtchizadeh N; Raeisi S; Ilghami H
    Sao Paulo Med J; 2016 May; 134(3):234-9. PubMed ID: 27191247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fish oil supplements on serum paraoxonase activity in female patients with rheumatoid arthritis: a double-blind randomized controlled trial.
    Ghorbanihaghjo A; Kolahi S; Seifirad S; Rashtchizadeh N; Argani H; Hajialilo M; Khabazi A; Alizadeh S; Bahreini E
    Arch Iran Med; 2012 Sep; 15(9):549-52. PubMed ID: 22924372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.
    Lehtimäki T; Laaksonen R; Janatuinen T; Vesalainen R; Nuutila P; Mattila K; Ilveskoski E; Luomala M; Saikku P; Knuuti J; Hurme M
    Pharmacogenetics; 2003 Oct; 13(10):633-9. PubMed ID: 14515062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
    Sentí M; Tomás M; Marrugat J; Elosua R;
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.